Dergi makalesi Açık Erişim

Primary antibody deficiencies in Turkey: molecular and clinical aspects

Firtina, Sinem; Ng, Yuk Yin; Ng, Ozden H.; Kiykim, Ayca; Ozek, Esra Yucel; Kara, Manolya; Aydiner, Elif; Nepesov, Serdar; Camcioglu, Yildiz; Sayar, Esra H.; Gungoren, Ezgi Yalcin; Reisli, Ismail; Torun, Selda H.; Haskologlu, Sule; Cogurlu, Tuba; Kaya, Aysenur; Cekic, Sukru; Baris, Safa; Ozbek, Ugur; Ozen, Ahmet; Ozen, Ahmet


MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ng, Yuk Yin</subfield>
    <subfield code="u">Istanbul Bilgi Univ, Dept Genet &amp; Bioengn, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ng, Ozden H.</subfield>
    <subfield code="u">Acibadem Mehmet Ali Aydinlar Univ, Acibadem Sch Med, Dept Med Biol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kiykim, Ayca</subfield>
    <subfield code="u">Istanbul Univ, Cerrahpasa Sch Med, Dept Infect Dis &amp; Clin Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozek, Esra Yucel</subfield>
    <subfield code="u">Istanbul Univ, Istanbul Sch Med, Dept Clin Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kara, Manolya</subfield>
    <subfield code="u">Dept Child Hlth &amp; Dis, Istanbul Med Pk, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Aydiner, Elif</subfield>
    <subfield code="u">Marmara Univ, Dept Pediat Allergy &amp; Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Nepesov, Serdar</subfield>
    <subfield code="u">Medipol Univ, Dept Pediat Allergy Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Camcioglu, Yildiz</subfield>
    <subfield code="u">Istanbul Univ, Cerrahpasa Sch Med, Dept Infect Dis &amp; Clin Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Sayar, Esra H.</subfield>
    <subfield code="u">Necmettin Erbakan Univ, Meram Med Fac, Dept Pediat Immunol &amp; Allergy, Konya, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Gungoren, Ezgi Yalcin</subfield>
    <subfield code="u">Marmara Univ, Dept Pediat Allergy &amp; Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Reisli, Ismail</subfield>
    <subfield code="u">Necmettin Erbakan Univ, Meram Med Fac, Dept Pediat Immunol &amp; Allergy, Konya, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Torun, Selda H.</subfield>
    <subfield code="u">Istanbul Univ, Istanbul Sch Med, Dept Clin Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Haskologlu, Sule</subfield>
    <subfield code="u">Ankara Univ, Dept Pediat Immunol &amp; Allergy, Sch Med, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Cogurlu, Tuba</subfield>
    <subfield code="u">Kocaeli Univ, Dept Pediat Immunol &amp; Allergy, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kaya, Aysenur</subfield>
    <subfield code="u">Dept Child Hlth &amp; Dis, Istanbul Med Pk, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Cekic, Sukru</subfield>
    <subfield code="u">Uludag Univ, Dept Pediat Immunol, Sch Med, Bursa, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Baris, Safa</subfield>
    <subfield code="u">Marmara Univ, Dept Pediat Allergy &amp; Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozbek, Ugur</subfield>
    <subfield code="u">Acibadem Mehmet Ali Aydinlar Univ, Acibadem Sch Med, Dept Med Genet, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozen, Ahmet</subfield>
    <subfield code="u">Marmara Univ, Dept Pediat Allergy &amp; Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozen, Ahmet</subfield>
    <subfield code="u">Marmara Univ, Dept Pediat Allergy &amp; Immunol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">IMMUNOLOGIC RESEARCH</subfield>
    <subfield code="v">70</subfield>
    <subfield code="n">1</subfield>
    <subfield code="c">44-55</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1007/s12026-021-09242-z</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Primary antibody deficiencies in Turkey: molecular and clinical aspects</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Firtina, Sinem</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:aperta.ulakbim.gov.tr:232722</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2022-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/232722/files/bib-3e4d125f-e11d-43a5-bf94-651519bf71ee.txt</subfield>
    <subfield code="z">md5:0209f42856c9aff70fab49b77a215d87</subfield>
    <subfield code="s">349</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20221007082909.0</controlfield>
  <controlfield tag="001">232722</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Primary antibody deficiencies (PAD) are the most common subtype of primary immunodeficiencies, characterized by increased susceptibility to infections and autoimmunity, allergy, or malignancy predisposition. PAD syndromes comprise of immune system genes highlighted the key role of B cell activation, proliferation, migration, somatic hypermutation, or isotype switching have a wide spectrum from agammaglobulinemia to selective Ig deficiency. In this study, we describe the molecular and the clinical aspects of fifty-two PAD patients. The most common symptoms of our cohort were upper and lower respiratory infections, bronchiectasis, diarrhea, and recurrent fever. Almost all patients (98%) had at least one of the symptoms like autoimmunity, lymphoproliferation, allergy, or gastrointestinal disease. A custom-made next-generation sequencing (NGS) panel, which contains 24 genes, was designed to identify well-known disease-causing variants in our cohort. We identified eight variants (15.4%) among 52 PAD patients. The variants mapped to BTK (n = 4), CD40L (n = 1), ICOS (n = 1), IGHM (n = 1), and TCF3 (n = 1) genes. Three novel variants were described in the BTK (p.G414W), ICOS (p.G60*), and IGHM (p.S19*) genes. We performed Sanger sequencing to validate pathogenic variants and check for allelic segregation in the family. Targeted NGS panel sequencing can be beneficial as a suitable diagnostic modality for diagnosing well-known monogenic PAD diseases (only 2-10% of PADs); however, screening only the coding regions of the genome may not be adequately powered to solve the pathogenesis of PAD in all cases. Deciphering the regulatory regions of the genome and better understanding the epigenetic modifications will elucidate the molecular basis of complex PADs.</subfield>
  </datafield>
</record>
40
4
görüntülenme
indirilme
Görüntülenme 40
İndirme 4
Veri hacmi 1.4 kB
Tekil görüntülenme 35
Tekil indirme 4

Alıntı yap